Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH).

Full DD Report for SBPH

You must become a subscriber to view this report.


Recent News from (NASDAQ: SBPH)

Spring Bank Pharmaceuticals, Inc. to Present at Upcoming Healthcare Conferences
HOPKINTON, Mass., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced that it will prese...
Source: GlobeNewswire
Date: November, 05 2018 08:00
Spring Bank Announces Three Poster Presentations on Its Next-Generation STING Agonist Program at the AACR Special Conference on Tumor Immunology and Immunotherapy
HOPKINTON, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced it will present da...
Source: GlobeNewswire
Date: November, 01 2018 08:00
Spring Bank Pharmaceuticals to Host R&D Day on Thursday, December 6, 2018
HOPKINTON, Mass., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced it will host a Res...
Source: GlobeNewswire
Date: October, 29 2018 11:00
Spring Bank Pharma beats by $0.01
Spring Bank Pharma (NASDAQ: SBPH ): Q3 GAAP EPS of -$0.59 beats by $0.01. More news on: Spring Bank Pharmaceuticals, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: October, 25 2018 17:11
Spring Bank Pharmaceuticals Reports Third Quarter Financial Results
HOPKINTON, Mass., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced its 2018 third qua...
Source: GlobeNewswire
Date: October, 25 2018 16:30
Spring Bank Pharmaceuticals, Inc. Appoints Scott Smith to its Board of Directors
Former Celgene President & COO Joins Spring Bank Board HOPKINTON, Mass., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory ...
Source: GlobeNewswire
Date: August, 16 2018 08:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-1412.2712.1512.4011.8676,266
2017-02-037.027.367.427.016,069
2017-02-027.7127.067.79996.9215,373
2017-02-017.73257.8297.867.5039,677
2017-01-317.207.747.837.190249,113

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-143471,16729.7344Cover
2018-12-1330783736.6786Short
2018-12-121,4136,68221.1464Cover
2018-12-118441,70949.3856Short
2018-12-101,1195,19221.5524Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on SBPH.


About Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH)

Logo for Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $184,160,461 - 05/18/2018
  • Issue and Outstanding: 13,182,567 - 04/26/2018

 


Recent Filings from (NASDAQ: SBPH)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 16 2018
Prospectus filed under Rule 424(b)(5)
Filing Type: 424B5Filing Source: edgar
Filing Date: August, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 09 2018
Prospectus filed under Rule 424(b)(5)
Filing Type: 424B5Filing Source: edgar
Filing Date: August, 08 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 02 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: August, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 01 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 19 2018
Amendment to a previously filed 10-Q
Filing Type: 10-Q/AFiling Source: edgar
Filing Date: May, 04 2018

 

 


Daily Technical Chart for (NASDAQ: SBPH)

Daily Technical Chart for (NASDAQ: SBPH)


Stay tuned for daily updates and more on (NASDAQ: SBPH)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: SBPH)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in SBPH is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of SBPH and does not buy, sell, or trade any shares of SBPH. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/